CRT 2023
Atherosclerosis and Vulnerable Plaque
Michael H. Joner, MD
Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany
Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)